> top > docs > PubMed:23564952 > annotations

PubMed:23564952 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-74 Sentence denotes Clinical relevance of the new IASLC/ERS/ATS adenocarcinoma classification.
TextSentencer_T2 75-326 Sentence denotes In 2011, recommendations for a multidisciplinary classification of lung adenocarcinoma were published under the auspices of the International Association for the Study of Lung Cancer, the American Thoracic Society and the European Respiratory Society.
TextSentencer_T3 327-556 Sentence denotes The review was considered necessary due to emerging data on the radiological features, genetics and therapeutic approaches to lung adenocarcinoma, all underpinned by expanding the knowledge of the pathology of this common tumour.
TextSentencer_T4 557-664 Sentence denotes The existing WHO classification of 2004 was not really fit for this multidisciplinary focus on the disease.
TextSentencer_T5 665-998 Sentence denotes This review describes the recommendations made on the reporting of surgically resected lung cancers according to their predominant pattern, and argues the case for replacing the term bronchioloalveolar carcinoma (WHO 1999 and 2004 definition) with adenocarcinoma in situ and for the introduction of minimally invasive adenocarcinoma.
TextSentencer_T6 999-1294 Sentence denotes There is also a discussion of diagnosis of non-small-cell lung carcinomas in the small biopsy or cytology setting, a practice that was inadequately addressed in WHO 2004, yet this is much more relevant to most pathologists' daily practice because 85% or so of adenocarcinomas are never resected.
TextSentencer_T7 1295-1408 Sentence denotes Predictive immunohistochemistry, used correctly, can reduce non-specific diagnosis to less than 10% of the cases.
TextSentencer_T8 1409-1591 Sentence denotes Finally, there is an overview of the emerging data on therapeutically relevant lung adenocarcinoma genetics, considering targetable mutations that are now the focus of much activity.
TextSentencer_T9 1592-1645 Sentence denotes The clinical relevance of these changes is discussed.
T1 0-74 Sentence denotes Clinical relevance of the new IASLC/ERS/ATS adenocarcinoma classification.
T2 75-326 Sentence denotes In 2011, recommendations for a multidisciplinary classification of lung adenocarcinoma were published under the auspices of the International Association for the Study of Lung Cancer, the American Thoracic Society and the European Respiratory Society.
T3 327-556 Sentence denotes The review was considered necessary due to emerging data on the radiological features, genetics and therapeutic approaches to lung adenocarcinoma, all underpinned by expanding the knowledge of the pathology of this common tumour.
T4 557-664 Sentence denotes The existing WHO classification of 2004 was not really fit for this multidisciplinary focus on the disease.
T5 665-998 Sentence denotes This review describes the recommendations made on the reporting of surgically resected lung cancers according to their predominant pattern, and argues the case for replacing the term bronchioloalveolar carcinoma (WHO 1999 and 2004 definition) with adenocarcinoma in situ and for the introduction of minimally invasive adenocarcinoma.
T6 999-1294 Sentence denotes There is also a discussion of diagnosis of non-small-cell lung carcinomas in the small biopsy or cytology setting, a practice that was inadequately addressed in WHO 2004, yet this is much more relevant to most pathologists' daily practice because 85% or so of adenocarcinomas are never resected.
T7 1295-1408 Sentence denotes Predictive immunohistochemistry, used correctly, can reduce non-specific diagnosis to less than 10% of the cases.
T8 1409-1591 Sentence denotes Finally, there is an overview of the emerging data on therapeutically relevant lung adenocarcinoma genetics, considering targetable mutations that are now the focus of much activity.
T9 1592-1645 Sentence denotes The clinical relevance of these changes is discussed.

DisGeNET

Id Subject Object Predicate Lexical cue
T0 40-43 gene:1287 denotes ATS
T1 44-58 disease:C0001418 denotes adenocarcinoma
T2 40-43 gene:81031 denotes ATS
T3 44-58 disease:C0001418 denotes adenocarcinoma
R1 T0 T1 associated_with ATS,adenocarcinoma
R2 T2 T3 associated_with ATS,adenocarcinoma

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 142-161 HP_0030078 denotes lung adenocarcinoma
T2 246-257 HP_0100526 denotes Lung Cancer
T3 251-257 HP_0002664 denotes Cancer
T4 453-472 HP_0030078 denotes lung adenocarcinoma
T5 549-555 HP_0002664 denotes tumour
T6 752-764 HP_0100526 denotes lung cancers
T7 757-764 HP_0002664 denotes cancers
T8 1042-1072 HP_0030358 denotes non-small-cell lung carcinomas
T9 1046-1072 HP_0030357 denotes small-cell lung carcinomas
T10 1052-1085 HP_0030357 denotes cell lung carcinomas in the small
T11 1488-1507 HP_0030078 denotes lung adenocarcinoma

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
23564952-0#40#43#gene1287 40-43 gene1287 denotes ATS
23564952-0#40#43#gene81031 40-43 gene81031 denotes ATS
23564952-0#44#58#diseaseC0001418 44-58 diseaseC0001418 denotes adenocarcinoma
40#43#gene128744#58#diseaseC0001418 23564952-0#40#43#gene1287 23564952-0#44#58#diseaseC0001418 associated_with ATS,adenocarcinoma
40#43#gene8103144#58#diseaseC0001418 23564952-0#40#43#gene81031 23564952-0#44#58#diseaseC0001418 associated_with ATS,adenocarcinoma

DisGeNet-2017-sample

Id Subject Object Predicate Lexical cue
T2640 40-43 gene:1287 denotes ATS
T2641 44-58 disease:C0001418 denotes adenocarcinoma
R1 T2640 T2641 associated_with ATS,adenocarcinoma
R2 T2640 T2641 associated_with ATS,adenocarcinoma

UBERON-AE

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 142-146 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
PD-UBERON-AE-B_T2 453-457 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
PD-UBERON-AE-B_T3 752-756 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
PD-UBERON-AE-B_T4 1057-1061 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
PD-UBERON-AE-B_T5 1488-1492 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 142-146 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
PD-UBERON-AE-B_T2 246-250 http://purl.obolibrary.org/obo/UBERON_0002048 denotes Lung
PD-UBERON-AE-B_T3 453-457 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
PD-UBERON-AE-B_T4 752-756 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
PD-UBERON-AE-B_T5 1057-1061 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
PD-UBERON-AE-B_T6 1488-1492 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung